NCT04435132

Brief Summary

This is a first-in-man (FIM) study to show feasibility and safety profile of the newly developed robotic device for percutaneous access in PCNL surgery. Patients with renal stone disease who had standard indications for prone PCNL were included in the study. PCNL was conducted with percutaneous puncture with the aid of robotic device with the use of intra-operative fluoroscopy. 5 patients were recruited in this pilot study over a period of 3 months. Punctures were performed by the board-qualified urologist.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 7, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 9, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 17, 2020

Completed
Last Updated

June 17, 2020

Status Verified

June 1, 2020

Enrollment Period

3 months

First QC Date

June 9, 2020

Last Update Submit

June 15, 2020

Conditions

Keywords

PCNLPercutaneous nephrolithotomy

Outcome Measures

Primary Outcomes (6)

  • Needle insertion time

    Time taken for PCNL procedure

    During procedure

  • Needle alignment time

    Time taken for needle alignment

    During procedure

  • Time to target

    Time taken for the needle to reach the calyx, from on the skin to successful needle targeting

    During procedure

  • Number of needle insertion attempts to obtain access

    Number of attempts before successfully reaching the calyx

    During procedure

  • Radiation dosage from placement of robot to efflux of urine

    A measure of the radiation exposed during the surgical procedure

    During procedure

  • Radiation dosage from placement of robot to successful needle target via image confirmation

    A measure of the radiation exposed during the surgical procedure

    During procedure

Study Arms (1)

PCNL with the aid of the robotic device

EXPERIMENTAL

Patients will undergo prone PCNL under fluoroscopic guidance and with the aid of the robotic device.

Device: PCL under fluoroscopy with the aid of the robotic device

Interventions

During the surgery, the robot was positioned over the estimated insertion point. It was aligned to be parallel to the fluoroscope imaging plane as much as possible. The needle is to be placed through the holder, and slightly penetrate the surface of the skin. An x-ray image is then taken to ensure that the whole device can be seen on the screen. Image calibration is then performed through the software GUI. After which, the clinician is also to perform needle tip selection. After which, needle alignment will then be performed. Once needle alignment is complete, the clinician will then advance the trocar needle into the patient's body, using the fluoroscopy to judge the penetration depth. Once the target has been reached, the needle style is to be extracted. The indication of leakage of fluid through the outer needle confirms the success of the procedure.

PCNL with the aid of the robotic device

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 21 to 75 years
  • Diagnosed with kidney stone disease and planned for prone PCNL with indication for surgery as per standard of care
  • Subject who understand the purpose of testing, voluntary and informed consent, patients undergoing invasive imaging follow-up.

You may not qualify if:

  • Bleeding disorders
  • Patient on anticoagulation/antiplatelets drugs
  • Pyonephrosis
  • Pregnant women
  • Not able to have prone position for the procedure due to comorbidities
  • Moderate to severe renal failure
  • The patient's life expectancy is less than 12 months
  • Poor compliance and patients unable to complete the study in accordance with the requirements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Malaya Medical Centre

Kuala Lumpur, 59100, Malaysia

Location

Related Publications (3)

  • Mozer P, Troccaz J, Stoianovici D. Urologic robots and future directions. Curr Opin Urol. 2009 Jan;19(1):114-9. doi: 10.1097/MOU.0b013e32831cc1ba.

    PMID: 19057227BACKGROUND
  • Cinquin P. How today's robots work and perspectives for the future. J Visc Surg. 2011 Oct;148(5 Suppl):e12-8. doi: 10.1016/j.jviscsurg.2011.08.003. Epub 2011 Oct 5. No abstract available.

    PMID: 21981795BACKGROUND
  • Oo MM, Gandhi HR, Chong KT, Goh JQ, Ng KW, Hein AT, Tan YK. Automated Needle Targeting with X-ray (ANT-X) - Robot-assisted device for percutaneous nephrolithotomy (PCNL) with its first successful use in human. J Endourol. 2021 Jun;35(6):e919. doi: 10.1089/end.2018.0003.

Related Links

MeSH Terms

Conditions

Kidney Calculi

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Patients will undergo prone PCNL under fluoroscopic guidance and with the aid of the robotic device. They will then be admitted to inpatient ward as per standard of care for PCNL.
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: Recruitment was carried out in University Malaya Medical Centre (UMMC) Hospital clinics and impatient wards. 5 patients were recruited with no preferred selection for gender or race. Patients recruited were set to be between 21 to 75 years of age. Patients presenting to to clinic or admitted to ward for renal stone disease were assessed for indications of PCNL. Patients were assessed for renal stone disease as per standard of care - imaging study with CT scan, renal function, clinical assessment of fitness and suitability for prone PCNL. Once patients were planned for prone PCNL, they will be informed about this study, the use of robotic device, potential benefits and complications by study investigators. If they are agreeable to informed consent, they will be recruited into the study.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2020

First Posted

June 17, 2020

Study Start

August 7, 2018

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

June 17, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations